Evidence map›Paper›PMID 40208480›Full record

ArticleMedical & biological engineering & computing2025

Incorporating frequency domain features into radiomics for improved prognosis of esophageal cancer.

Shu Chen, Shumin Zhou, Liyang Wu, Shuchao Chen, Shanshan Liu, Haojiang Li, Guangying Ruan, Lizhi Liu, Hongbo Chen

Abstract read
PubMed Publisher
In one paragraph

Article in Medical & biological engineering & computing, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Shu Chen *School of Life & Environmental Science, Guilin University of Electronic Technology, Guilin, 541004, China.
Shumin Zhou *State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangdong Esophageal Cancer Institute, Guangzhou, 510060, China.
Liyang WuSchool of Life & Environmental Science, Guilin University of Electronic Technology, Guilin, 541004, China.
Shuchao ChenSchool of Life & Environmental Science, Guilin University of Electronic Technology, Guilin, 541004, China.
Shanshan LiuSchool of Life & Environmental Science, Guilin University of Electronic Technology, Guilin, 541004, China.
Haojiang LiState Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangdong Esophageal Cancer Institute, Guangzhou, 510060, China.
Guangying RuanState Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangdong Esophageal Cancer Institute, Guangzhou, 510060, China.
Lizhi LiuState Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangdong Esophageal Cancer Institute, Guangzhou, 510060, China. liulizh@sysucc.org.cn.
Hongbo ChenSchool of Life & Environmental Science, Guilin University of Electronic Technology, Guilin, 541004, China. hongbochen@163.com.ORCID http://orcid.org/0000-0002-0389-7875

Funding

Guangdong Esophageal Cancer Institute Science and Technology Plan Project M202016Guangdong Esophageal Cancer Institute Youth Project Q202214the National Natural Science Foundation of China 82171906the National Natural Science Foundation of China 82260358
6 · The paper itself

Abstract

Esophageal cancer is a highly aggressive gastrointestinal malignancy with a poor prognosis, making accurate prognostic assessment essential for patient care. The performance of the esophageal cancer prognosis model based on conventional radiomics is limited, as it mainly characterizes the spatial features such as texture of the tumor area, and cannot fully describe the complexity of esophageal cancer tumors. Therefore, we incorporate the frequency domain features into radiomics to improve the prognostic ability of esophageal cancer. Three hundred fifteen esophageal cancer patients participated in the death risk prediction experiment, with 80% being the training set and 20% being the testing set. We use fivefold cross validation for training, and fuse the 5 trained models through voting to obtain the final prognostic model for testing. The CatBoost achieved the best performance compared to machine learning methods such as random forests and decision tree. The experimental results showed that the combination of frequency domain and radiomics features achieved the highest performance in death predicting esophageal cancer (accuracy: 0.7423, precision: 0.7470, recall: 0.7375, specification: 0.8030, AUC: 0.8487), which was significantly better than the performance of frequency domain or radiomics features alone. The results of Kaplan-Meier survival analysis validated the performance of our method in death predicting esophageal cancer. The proposed method provides technical support for accurate prognosis of esophageal cancer.

Indexed as

Esophageal NeoplasmsAgedFemaleHumansKaplan-Meier EstimateMachine LearningMaleMiddle AgedPrognosisRadiomicsTomography, X-Ray ComputedEsophageal cancerFeature fusionFrequency domain featuresPrognostic predictionRadiomics

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.